HerbalVet Tumor Bio: Veterinary Product Profile

HerbalVet Tumor Bio is a named branded product for Dogs and cats; manufacturer positioning is kept separate from independent clinical and regulatory evidence.

glycerin-based oral mushroom-extract liquid in 60 mL, 100 mL, and 200 mL presentations. Intended species: Dogs and cats.

The official page lists organic dried Cordyceps sinensis, Agaricus blazei Murrill, Grifola frondosa, Lentinula edodes, and Ganoderma lucidum extracts at a stated total mushroom concentration of 0.06 g/mL, with glycerin 0.9 g/mL. Its per-3 mL composition section lists 0.04 g of each extract and declared polysaccharide percentages of 85% for Cordyceps, 69% for Agaricus, 60% for Maitake, 76% for Shiitake, and 31% for Reishi, with 0.12 g declared polysaccharides per 3 mL. The package should be checked because the aggregate figures require manufacturer clarification.

HerbalVet markets Tumor Bio as a five-mushroom combination for immune support and adjunctive use during tumour care and chemotherapy. The page makes broad oncology and biological-mechanism statements. These are the manufacturer's positioning and should not be represented as a clinical result of the finished liquid.

May be discussed only as supportive care within a veterinarian-led plan; it must not replace diagnosis, staging, standard treatment, symptom control, or emergency care.

Define a modest supportive objective, baseline, review date, adverse-event plan, and stopping rule with the veterinarian.

Bring the current label, lot, full ingredient panel, country version, complete diet, medicines, and supplements to the treating veterinarian.

The official page supports current identity, species, presentations, ingredients, declared analytical information, and the manufacturer-stated NÉBIH number 1775/2/NM/2020. No controlled canine or feline oncology trial of this five-mushroom finished product was identified. Findings for purified PSP, PSK, another mushroom extract, cells, or people do not establish equivalence.

The official page cautions about concurrent anticoagulant medicines and insulin. The multi-mushroom formula also requires review for mushroom allergy, gastrointestinal effects, autoimmune disease, immunosuppressive or immune-directed treatment, diabetes, bleeding, surgery, pregnancy, and glycerin exposure. The apparently inconsistent aggregate composition figures should be clarified before calculating any ingredient exposure.

No universal compatibility conclusion is made. Review the complete label and individualized treatment plan with the veterinarian.

The manufacturer states Hungarian NÉBIH registration number 1775/2/NM/2020. The reviewed NÉBIH framework covers categories of veterinary therapeutic-effect preparations, animal-care products, and auxiliaries; a manufacturer-listed number is not proof of EU authorisation as an antineoplastic veterinary medicine. Exact register category should be confirmed before public launch.

Hungary; European Union

Retain the bottle and Hungarian or export label, record lot, presentation, formula totals, medicines, and treatment dates. Track appetite, vomiting, stool, skin signs, energy, weight, bruising or bleeding, and glucose when the veterinarian considers it relevant. Do not alter insulin, anticoagulants, chemotherapy, or tumour monitoring because of a web description.